REVIEW
|
doi:10.20944/preprints202310.0910.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immune checkpoint inhibitor; resistance mechanism; melanoma; oral mucosal melanoma; immunotherapy; immune checkpoint blockade; anti-PD-1; anti-CTLA-4
Online: 17 October 2023 (03:37:34 CEST)